Skip to main content
. 2022 Dec 5;12:21020. doi: 10.1038/s41598-022-25180-8

Table 3.

Results of sensitivity analyses using alternative diagnostic criteria for PD.

Variables Events PY Crude IR (per 100,000 PY) Adjusted HR (95% CI)a
Model 1b Model 2c Model 3d
Antiparkinsonian drug and ≥ 1 ICD-10 code
Total cholesterol levels (tertiles)
Lowest 884 599,561 147.4 1.15 (1.04–1.28)* 1.13 (1.02–1.26)* 1.13 (1.02–1.25)*
Middle 589 535,763 109.9 1.00 1.00 1.00
Highest 584 574,552 101.6 1.02 (0.91–1.14) 1.03 (0.92–1.15) 1.03 (0.92–1.16)
LDL cholesterol levels (tertiles)
Lowest 845 584,294 144.6 1.14 (1.03–1.27)* 1.13 (1.01–1.25)* 1.12 (1.01–1.24)*
Middle 623 544,029 114.5 1.00 1.00 1.00
Highest 589 581,553 101.3 0.97 (0.86–1.08) 0.98 (0.98–1.09) 0.98 (0.87–1.10)
HDL cholesterol levels (tertiles)
Lowest 661 480,304 137.6 1.01 (0.91–1.13) 1.00 (0.90–1.11) 1.00 (0.90–1.11)
Middle 763 615,496 124.0 1.00 1.00 1.00
Highest 633 614,076 103.1 0.89 (0.81–0.99)* 0.89 (0.81–1.00)* 0.91 (0.82–1.01)
Triglyceride levels (tertiles)
Lowest 680 585,809 116.1 0.98 (0.88–1.08) 1.00 (0.88–1.09) 1.00 (0.89–1.10)
Middle 736 572,340 128.6 1.00 1.00 1.00
Highest 641 551,726 116.2 0.99 (0.89–1.10) 0.98 (0.88–1.09) 0.99 (0.89–1.10)
≥ 1 admission or ≥ 2 ambulatory visits with PD, and ≥ 1 PD diagnosis by a neurologist
Total cholesterol levels (tertiles)
Lowest 645 606,030 106.4 1.19 (1.05–1.35)** 1.17 (1.03–1.33)* 1.17 (1.03–1.33)*
Middle 395 539,618 73.2 1.00 1.00 1.00
Highest 379 579,933 65.4 1.00 (0.87–1.15) 1.01 (0.87–1.16) 1.01 (0.88–1.16)
LDL cholesterol levels (tertiles)
Lowest 625 590,833 105.8 1.30 (1.14–1.47)*** 1.28 (1.13–1.45)*** 1.27 (1.12–1.44)***
Middle 392 548,036 71.5 1.00 1.00 1.00
Highest 402 586,711 68.5 1.07 (0.93–1.23) 1.07 (0.93–1.23) 1.08 (0.94–1.24)
HDL cholesterol levels (tertiles)
Lowest 467 485,247 96.2 1.02 (0.90–1.16) 1.01 (0.89–1.15) 1.01 (0.89–1.15)
Middle 528 621,153 85.0 1.00 1.00 1.00
Highest 424 619,179 68.5 0.87 (0.76–0.99)* 0.87 (0.87–0.99)* 0.88 (0.77–1.00)*
Triglyceride levels (tertiles)
Lowest 482 590,083 81.7 0.98 (0.88–1.08) 0.99 (0.87–1.12) 0.99 (0.87–1.12)
Middle 499 577,624 86.4 1.00 1.00 1.00
Highest 438 557,873 78.5 0.99 (0.89–1.10) 1.01 (0.89–1.15) 1.02 (0.89–1.16)
 ≥ 1 admission or ≥ 2 ambulatory visits with extended definition of PDe
Total cholesterol levels (tertiles)
Lowest 1057 603,531 175.1 1.18 (1.07–1.30)*** 1.16 (1.05–1.28)** 1.15 (1.04–1.27)**
Middle 663 538,077 123,2 1.00 1.00 1.00
Highest 642 578,481 111.0 1.00 (0.90–1.11) 1.01 (0.90–1.12) 1.01 (0.91–1.13)
LDL cholesterol levels (tertiles)
Lowest 1012 588,433 172.0 1.24 (1.22–1.37)*** 1.22 (1.10–1.34)*** 1.20 (1.09–1.33)***
Middle 670 546,433 122.6 1.00 1.00 1.00
Highest 680 585,223 116.2 1.04 (0.94–1.16) 1.05 (0.95–1.17) 1.06 (0.95–1.18)
HDL cholesterol levels (tertiles)
Lowest 769 483,438 159.1 1.02 (0.93–1.12) 1.01 (0.91–1.11) 1.01 (0.91–1.11)
Middle 873 619,174 141.0 1.00 1.00 1.00
Highest 720 617,477 116.6 0.89 (0.81–0.99)* 0.90 (0.82–0.99)* 0.90 (0.82–1.00)*
Triglyceride levels (tertiles)
Lowest 797 588,259 135.5 0.95 (0.87–1.05) 0.96 (0.87–1.06) 0.96 (0.87–1.06)
Middle 860 575,682 149.4 1.00 1.00 1.00
Highest 705 55,6147 126.8 0.94 (0.85–1.04) 0.94 (0.85–1.03) 0.94 (0.85–1.04)

IR, incidence rate; PY, person years; HR, hazard ratio; CI, confidence interval; LDL, low-density lipoprotein; HDL, high-density lipoprotein; PD, Parkinson’s disease.

aFor each blood lipid fraction, separate time-dependent Cox regression models was fitted.

bAdjusted for age, sex, area of residence, smoking status, alcohol consumption, levels of physical activity, and BMI.

cAdjusted for age, sex, area of residence, smoking status, alcohol consumption, levels of physical activity, BMI, and past medical history (stroke, diabetes mellitus, and hypertension).

dAdjusted for age, sex, area of residence, smoking status, alcohol consumption, levels of physical activity, BMI, past medical history (stroke, diabetes mellitus, and hypertension), and cumulative duration of statin usage.

eParkinson’s disease (ICD G20), other forms of secondary parkinsonism (ICD-10 codes G21 and G22), other degenerative diseases in basal ganglia (ICD-10 code G23), and movement disorders in diseases classified elsewhere (ICD-10 code G26).

***p < 0.001; **p < 0.01; *p < 0.05.